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Correction ￿9 The  Journal of Experimental Medicine 
In the article "Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase 
gene targeted by platelet growth  glycoprotein Ilb promoter" by D. Tronik-Le  Roux, V. Roullot, A. Schweitzer, R. Berthier, and G. Marguerie (June 
1995, 181:2141-2151), some data were left out of Tables 1 and 3. The complete tables appear below. 
Table  1.  Effect  of GCV Treatment on Blood Cell Counts 
Control mouse  alIbtk mouse 
DO  D10  D23  DO  D10  D23 
Erythrocytes  10.91  +  2.3  10.93  -+  1.13  10.88  +  0.5  10.69  -+ 3.053  9.23  -+ 0.59  3.12  +  0.88 
(X 1012) 
Leukocytes  10.19  -+  1.5  12.33  +  4.0  13.00  +  1.0  8.33  +  4.27  8.15  +  1.65  13.59  -+  14.08 
(￿  lO 9) 
Platelets  0.80  +  0.09  0.93  +- 0.18  0.77  +  0.14  0.73  +  0.12  0.045  +  0.012  0.02  +- 0.007 
(X  1012) 
Mean peripheral blood cell counts (+ SD) of control and transgenic edlbtk mice (n =  5) before (DO), 10 d (D10), or 23 d (D23) of GCV 
(0.05  mg/g per d) treatment. The counts shown are per liter of blood volume. 
Table  3.  Number of Monopotent and Mixed Myeloid Colonies  from BM cells of Control and alIbtk Mice Treated with GCV 
GEM  +  GEMK 
GM-CFC  BFU-E  MK  BFU-E-MK  +  GMMK  GEMMK 
Experiment 1 
Control  64  -+  11.5  12  +  1.8  4  +  1.7  4.5  -+  1.1  8.5  -+ 3.6  2.2  +  0.8 
alIbtk  61  +  3.3  0.6  +  0.5  1.4  +  0.9  0.6  +  0.9  1.6  +  1.5  0.4  +  0.5 
Experiment 2 
Control  71  -+ 8.5  8  +  3.3  9  -+ 2.2  2.2  +  0.8  4  -+  1.6  2  -+  1 
~xlIbtk  59  +  7.4  0.75  -+ 0.5  0.25  +  0.5  0  0  0 
Marrow cells (5 ￿  104/ml per dish)  from control and alIbtk mice treated with GCV (1 mg/d for 10 d) were obtained by femoral aspiration 
and plated in 1 ml of culture medium as described in Materials and Methods.  The number of colonies was the mean SD of five identical 
dishes.  Mixed colonies consisted ofbilineage BFU-E-MK (erythroid and megakaryocytic), trilineage GEM (granulocytic erythroid macroph- 
agic),  GEMK  (granulocytic  erythroid  megakaryocytic),  GMMK  (granulocytic  macrophagic  megakaryocytic),  and  multipotent  GEMMK 
(granulocytic erythroid macrophagic and megakaryocytic). 